Depression and Bipolar Disorders
Mood disorders span a continuum from depression at one end to mania at the other. The DSM-5 separates depressive disorders from bipolar disorders, recognizing they have different courses, genetics, and treatments.
Major Depressive Disorder (MDD)
Major depressive disorder requires a major depressive episode: at least five symptoms present for at least 2 weeks, including either depressed mood or anhedonia (loss of interest/pleasure). Other symptoms include:
- Significant weight change or appetite change.
- Insomnia or hypersomnia.
- Psychomotor agitation or retardation.
- Fatigue or low energy.
- Feelings of worthlessness or excessive guilt.
- Impaired concentration or indecisiveness.
- Recurrent thoughts of death or suicide.
Mnemonic: SIG E CAPS (Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor, Suicide) plus mood.
Women are diagnosed with MDD about twice as often as men. Peak onset is in the 20s-30s. Lifetime prevalence is 15-20%.
Persistent Depressive Disorder (Dysthymia)
Persistent depressive disorder is a chronic, milder form of depression lasting at least 2 years (1 year in children). Symptoms overlap with MDD but are less severe, and there are no symptom-free periods longer than 2 months. Sometimes called “low-grade depression” - the person functions, but poorly and unhappily.
Bipolar Disorders
Bipolar disorders involve alternating episodes of depression and mania.
Manic Episode
At least 1 week of elevated, expansive, or irritable mood and increased energy, plus at least 3 additional symptoms (4 if mood is only irritable):
- Inflated self-esteem or grandiosity.
- Decreased need for sleep.
- More talkative than usual; pressure to keep talking.
- Flight of ideas (rapid topic changes).
- Distractibility.
- Increase in goal-directed activity.
- Excessive involvement in high-risk pleasurable activities (unprotected sex, spending sprees, reckless driving).
Mnemonic: DIG FAST (Distractibility, Irritability, Grandiosity, Flight of ideas, Agitation/Activity, Sleep decreased, Talkativeness).
Mania can severely impair judgment and often requires hospitalization.
Bipolar I
At least one manic episode. Most people with bipolar I also have depressive episodes, but depression is not required for diagnosis.
Bipolar II
At least one major depressive episode and at least one hypomanic episode (a less severe form of mania that lasts at least 4 days and doesn’t cause marked impairment). Never a full manic episode - the presence of one upgrades the diagnosis to bipolar I.
Cyclothymic Disorder
A chronic but milder form: alternating periods of hypomanic and depressive symptoms for at least 2 years, without meeting criteria for a full episode.
Biological Basis
Monoamine Hypothesis of Depression
Depression involves deficiency in monoamine neurotransmitters, particularly serotonin, norepinephrine, and dopamine. Evidence:
- SSRIs (selective serotonin reuptake inhibitors) and other antidepressants that boost these monoamines effectively treat depression in many patients.
- Reserpine (old antihypertensive that depleted monoamines) caused depression.
- Brain imaging often shows altered activity in prefrontal cortex, amygdala, hippocampus.
The hypothesis is incomplete - antidepressants boost monoamines within hours but take weeks to produce clinical benefit, suggesting downstream neuroplastic changes matter more than the neurotransmitter level itself.
Other Findings
- Anterior cingulate cortex shows reduced serotonin responsiveness in depression.
- Chronic stress elevates cortisol and damages the hippocampus; people with depression often have smaller hippocampi.
- Learned helplessness (Seligman) is an animal model of depression.
- Genetic. Heritability ~40% for MDD, ~70% for bipolar.
Treatment
Antidepressants
- SSRIs (fluoxetine, sertraline, escitalopram) - block serotonin reuptake. First-line for depression. Minor side effects, low overdose risk.
- SNRIs (venlafaxine, duloxetine) - block serotonin and norepinephrine reuptake.
- Tricyclic antidepressants (amitriptyline, nortriptyline) - older, more side effects, higher overdose risk.
- MAOIs - block monoamine oxidase, preventing breakdown of monoamines. Effective but require dietary restrictions (tyramine crisis) and have many drug interactions.
All antidepressants take 4-6 weeks for full effect.
Mood Stabilizers for Bipolar
- Lithium - the classic mood stabilizer. Reduces mania and prevents relapse. Narrow therapeutic window - blood levels must be monitored. Mechanism incompletely understood.
- Anticonvulsants (valproate, lamotrigine, carbamazepine) - also effective as mood stabilizers.
Antidepressants given alone to bipolar patients can trigger a manic episode - so mood stabilizers are often co-prescribed.
Psychotherapy
- Cognitive behavioral therapy (CBT) - challenges distorted thought patterns. Evidence-based first-line psychotherapy.
- Interpersonal therapy - focuses on relationship patterns.
- Electroconvulsive therapy (ECT) - for severe, treatment-resistant depression. Induces brief seizures under anesthesia. Highly effective but carries memory side effects.
- Transcranial magnetic stimulation (TMS) - non-invasive alternative to ECT, approved for treatment-resistant depression.